Comment by
Pandora on Sep 20, 2021 7:30pm
And looking at the dates it is always nice to know that there is never any urgency in resolving any of this cancer stuff. Not like a warp speed for a covid vaccine. But that's alright, cancer has been around for years -- it's effects in death and such are just considered normal, standard fare.
Comment by
MuskieMan50 on Sep 20, 2021 8:46pm
Eog, Very interesting summation there.It is such a human tragedy that all of these indications are just sitting there idly.I have always felt that the technology deserves to be in hands where there is ample money to futher adavance it.I think there was some kind of a deal in the works.Another poster had suggested this a bit ago.I will find it and bump it up
Comment by
99942Apophis on Sep 21, 2021 9:47am
Thanks socks for that chuckle, that fictional list would be extremely long with perhaps names like IBM? Anyone else with names to contribute to this fictional list, please add your candidate.
Comment by
CAinPlap on Sep 21, 2021 10:02am
Let's issue a challenge to Richard Branson and Elon Musk to compete in the race to beat cancer rather than the race to Mars. One picks TLT to pour resources into while the other baclks another promising horse. Appeal to their egos that they can be the person who cured cancer.
Comment by
Longholder99 on Sep 21, 2021 12:56pm
Or it pops on news on results or partnerships....and warrants bring in cash. Seems like a manufactured concern.this money thing that certain posters keep bringing up
Comment by
StevenBirch on Sep 21, 2021 1:22pm
I agree 100%. There should be more than enough data alone in the next 3 to 4 months to get it to pop, maybe even in the next update.
Comment by
stocksnbonds458 on Sep 21, 2021 8:02pm
I agree 100% skys, we should be at the point by next year that when we need money the funds should be there for us.
Comment by
tamarindo1 on Sep 21, 2021 1:24pm
This was last February: maybe we can make eyes at him. :-)) WELL Health Announces Major Expansion into U.S. Market with Proposed Acquisition of CRH Medical and Concurrent C$295.5M Equity Offering Led by Mr. Li Ka-Shing at a 25% Premium to Market